
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
CLINICAL EVALUATION OF CODED DRUGS UNIM-304 & UNIM-312 ALONG WITH MUNZIJ (UNIM-308), MUSHIL (UNIM-309) AND TABREED (UNIM-310) THERAPY IN WAJA-UL-MAFASIL (RHEUMATOID ARTHRITIS)
*Shamsul Arfeen, W. Zaman, M. R. Kidwai, Jamal Akhtar, Naheed Parveen and M. A. Khan
Abstract Each participant was well informed about the trial and written consent was obtained before initiation of the study. Demographic data and information on the present disease condition, concomitant disease and therapy was recorded. Thorough general physical and systemic clinical examination was carried out. Signs and Symptoms pertaining to Rheumatoid arthritis were recorded in CRF. The vital parameters like blood pressure, heart rate, temperature and respiratory rate were also recorded. X-Ray of affected joints was conducted and blood samples were collected for the evaluation of laboratory parameters like Haemogram, C-Reactive proteins and Rheumatoid factor to establish and confirm inclusion criteria and other laboratory test like complete blood picture, kidney function test, liver function test and routine and microscopic examination of urine were done. All clinical and laboratory followup were done at every 4 weeks. Keywords: Waja-ul-mafasil, UNIM, Rheumatoid arthritis, Unani medicine, Remission. [Full Text Article] [Download Certificate] |
